Sectors

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.

Q&A with Veronica Gabriele, associate, Munich Re Ventures

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The utility company has backed Energy Impact Partners’s latest fund that targets clean energy companies owned by diverse founders.

Israel-based specialty minerals and chemicals group has launched its programme to support businesses in the food tech and agtech space.

The offering would produce $500m, including up to $70.6m from the sale of new shares, and offer exits to Max Group and TVS.

Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.

Tiger Global has led another round for Infra.Market, having done the same six months ago when Sistema Asia Fund also invested.

The corporate-backed consumer credit platform operator will get a Nasdaq listing from the transaction, which will include $120m in Pipe financing co-led by Palantir Technologies.

SoftBank helped the raw materials procurement company secure $160m in a series E round, which will finance its acquisition strategy.